# Meeting at Kobayashi Pharmaceutical Co., Ltd.


    In the meeting room of Kobayashi Pharmaceutical Co., Ltd., arge assembly of coteral members from the Kobayashi family and corporate executives sat, visibly uneasy.


    Recent events had left the atmosphere tense, with a series of rming incidents rattling everyone present. First, the former president met a tragic end due to poisoning, followed closely by suspicions surrounding the young master, who was used of poisoning his own father.<fnbc4e> Find the newest release on FιndＮovel</fnbc4e>


    Despite the unease, there was a glimmer of hope among the attendees as they anticipated a brighter future. Previously, most of them had little involvement in the operations of Kobayashi Pharmaceuticals, often receiving only minimal profits. However, that was about to change.


    Now, Masayoshi Kobayashi had stepped in as the acting president, promising to allocate at least 40% of thepany’s profits. If he could deliver on this promise, each person in the room stood to see their annual ie soar by more than ten times.<h3 style="background-color:DodgerBlue">


    Just then, Masayoshi Kobayashi entered the meeting room with an air of confidence. All eyes turned to him, and in that moment, he was seen as the source of potential wealth for everyone.


    Upon entering, Masayoshi walked straight to the head of the conference table, prompting everyone to rise in respect. It was then that someone, not identified, enthusiastically eximed, “Wee, President!”


    The room quickly echoed with a chorus of, “Wee, President!” as warm apuse followed.


    Feeling gratified, Masayoshi smiled and remarked, “There’s no need for such formalities. I’m still just the president of Kobayashi Pharmaceutical. If we make too much noise, outsiders might start to talk!”


    The individual who had first praised him responded eagerly, “Mr. Kobayashi, in our eyes, you are the true president of Kobayashi Pharmaceutical!”


    Masayoshi beamed with pride but quickly adopted a serious demeanor, saying, “I genuinely hope that Mr. Jiro Kobayashi can return to Kobayashi Pharmaceutical soon to take charge of thepany’s overall operations. Until then, I’m merely filling in for him!”


    He gestured for everyone to take their seats. Once settled, he continued earnestly, “As you all know, Kobayashi Pharmaceutical is facing both internal and external challenges. Recently, I learned about a Chinesepany called Oracle Pharmaceutical that has introduced a product named Nova Dias. This new medication is reportedly significantly more effective than our own Niranex. However, due to their limited production capacity, it hasn’t yet reached the Japanese market.”


    One member of the group quickly interjected, “Sir, I must inform you that my son-inw visited Chinast week and learned about this drug. He bought a box at a premium price, and after trying it yesterday, I must say it outperforms our Niranex by a considerable margin!”


    Kobayashi Masayoshi responded gravely, “If that’s the case, Oracle Pharmaceutical could very well be our next majorpetitor!”


    After a brief pause, he continued, “With their product proving to be more effective, if this trend continues, their production will ramp up while our sales will dwindle. If Nova Dias enters the global market, it could severely impact our revenue from Niranex!”


    The room fell silent, with expressions of shock and concern etched on everyone’s faces.